Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Comparing Pain and Swelling After Surgical Extraction of Mandibular Third Molar in Dexamethasone Injection and Without Corticosteroid Methods

6. juli 2013 opdateret af: Mohammad Javad Shirani
In some cases, impacted wisdom teeth should be extracted. Surgical extraction of these impacted third molars may provide special complication as pain, swelling, and trismus. In previous studies, some techniques as sutureless flap closure, modified flap designing, antibiotic usage, and injection of corticosteroids were presented. These methods are reducing post operative complications to moderate level. In this study, pain, swelling, trismus, general patients' satisfaction, and associated quality of life after the surgical removal of third mandibular impacted molars will be compared while injection of dexamethasone (8mg) does not need excessive time, effort, and equipments and it will be injected in numbness area into medial pterygoid muscle and pterygomandibular space to current corticosteroid injecting non-corticosteroid methods. To achieve this aim, 75 non pregnant participants have single impacted mandibular third molar in healthy and without pericoronitis manner, after provision of written informed consent will be entered to the study. During the study, unwilling participants to continue the study and those with abnormality of wound healing process will be excluded. The included participants will be assigned into three 25-people groups. The surgeries were done by 3 same instructed experienced oral and maxillofacial residents. After the surgery pain, swelling, trismus, general patients' satisfaction, and associated quality of life were evaluated using interview of questionnaire in 48 hour, 96 hour, and one week period of time. The comparison was done between these three groups.

Studieoversigt

Status

Ukendt

Betingelser

Intervention / Behandling

Undersøgelsestype

Interventionel

Tilmelding (Forventet)

75

Fase

  • Fase 4

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

  • Iran, Islamisk Republik
      • Isfahan, Iran, Islamisk Republik, 81745-319
        • Rekruttering
        • Department of oral and maxillofacial surgery, Faculty of Dentistry, Isfahan University of Medical Sciences
        • Kontakt:
        • Ledende efterforsker:
          • Mohammadjavad Shirani, Dr

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år til 35 år (Voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  • Non pregnant participants have single impacted mandibular third molar in healthy and without pericoronitis manner
  • They must have no contra-indication for injection of the corticosteroid and lidocaine with epinephrine
  • Should not medicated by any possibly bias maker drug
  • Type of the impaction, must not provide sever difficulty
  • The participants should be mentally at healthy level and provide written informed consent to incorporate in the study

Exclusion Criteria:

-Unwilling participants to continue the study and those with abnormality of wound healing process

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Støttende pleje
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Tredobbelt

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Aktiv komparator: Dexamethazone IO
For the case group, after the inferior alveolar block injection and before starting the surgery, single dose of dexamethasone (8mg) will injected into medial pterygoid and pterygomandibular space
Medicin: 21-benzyloxy-9alpha-fluoro-16alpha-methylpregna-1,4-dien-11beta,17alpha-diol-3,20-dione
single dose of dexamethasone (8mg) will injected
Aktiv komparator: Dexamethasone IM
For the case group, after the inferior alveolar block injection and before starting the surgery, single dose of dexamethasone (8mg) will injected into medial pterygoid and pterygomandibular space
Medicin: 21-benzyloxy-9alpha-fluoro-16alpha-methylpregna-1,4-dien-11beta,17alpha-diol-3,20-dione
single dose of dexamethasone (8mg) will injected

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Changes in Pain
Tidsramme: 48 hours and one week after intervention
Visual analogue scale of pain- Number of required analgesics tablets
48 hours and one week after intervention
Changes in Swelling
Tidsramme: 48 hours and one week after intervention
Questionnaire and VAS
48 hours and one week after intervention
Changes in Trismus
Tidsramme: 48 hours and one week after intervention
Questionnaire
48 hours and one week after intervention
Changes in General patients' satisfaction
Tidsramme: 48 hours and one week after intervention
Visual analogue scale for satisfaction
48 hours and one week after intervention
Changes in Quality of life
Tidsramme: 96 hours and one week after intervention
Questionnaire
96 hours and one week after intervention

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Trismus
Tidsramme: one week period after the surgery
Questionnaire about Maximum mouth opening- Patients complaint
one week period after the surgery

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Mohammad Javad Shirani

Samarbejdspartnere

Isfahan University of Medical Sciences

Efterforskere

  • Studiestol: Bijan Movahedian, Oral and maxillofacial surgeon, Department of oral and maxillofacial surgery, Faculty of Dentistry, Isfahan University of Medical Sciences

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart

1. april 2013

Primær færdiggørelse (Forventet)

1. april 2014

Datoer for studieregistrering

Først indsendt

30. juni 2013

Først indsendt, der opfyldte QC-kriterier

6. juli 2013

Først opslået (Skøn)

11. juli 2013

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Skøn)

11. juli 2013

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

6. juli 2013

Sidst verificeret

1. juli 2013

Mere information

Begreber relateret til denne undersøgelse

Nøgleord

Andre undersøgelses-id-numre

  • 292037 (Andet bevillings-/finansieringsnummer: Isfahan University of Medical Sciences)
  • IRCT2013042713140N1 (Registry Identifier: Iranian Registry of clinical trials)

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Kliniske forsøg med Molar, Tredje

Kliniske forsøg med 21-benzyloxy-9alpha-fluoro-16alpha-methylpregna-1,4-dien-11beta,17alpha-diol-3,20-dione

Søg i lignende forsøg

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

CROs by country

CROs in Argentina

Betingelser

Sjældne sygdomme

Narkotikainterventioner

Kosttilskud

Sponsor / samarbejdspartnere

Placeringer

Abonner